no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection
|
Lima, Danielle Malta |
|
2011 |
29 |
4 |
p. 831-838 8 p. |
article |
2 |
Analysis of porcine circovirus type 1 detected in Rotarix vaccine
|
Baylis, Sally A. |
|
2011 |
29 |
4 |
p. 690-697 8 p. |
article |
3 |
A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer
|
Vendrell, Alejandrina |
|
2011 |
29 |
4 |
p. 728-736 9 p. |
article |
4 |
A plasmid DNA immunogen expressing fifteen protein antigens and complex virus-like particles (VLP+) mimicking naturally occurring HIV
|
Somogyi, Eszter |
|
2011 |
29 |
4 |
p. 744-753 10 p. |
article |
5 |
Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models
|
Xu, Xin-Gang |
|
2011 |
29 |
4 |
p. 636-643 8 p. |
article |
6 |
CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine
|
Guo, Xiaoti |
|
2011 |
29 |
4 |
p. 772-777 6 p. |
article |
7 |
Civil society: A critical new advocate for vaccination in Europe
|
Laurent-Ledru, Vanina |
|
2011 |
29 |
4 |
p. 624-628 5 p. |
article |
8 |
Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates
|
Safari, Dodi |
|
2011 |
29 |
4 |
p. 849-854 6 p. |
article |
9 |
Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus
|
Zhang, Deqing |
|
2011 |
29 |
4 |
p. 629-635 7 p. |
article |
10 |
Corrigendum to “A liposome-based platform, VacciMax®, and its modified water-free platform DepoVax™ enhance efficacy of in vivo nucleic acid delivery” [Vaccine 28 (2010) 6176–6182]
|
Karkada, Mohan |
|
2011 |
29 |
4 |
p. 863- 1 p. |
article |
11 |
Editorial Board/Aims and Scope
|
|
|
2011 |
29 |
4 |
p. CO2- 1 p. |
article |
12 |
Envelope protein E1 as vaccine target for western equine encephalitis virus
|
Swayze, Richard D. |
|
2011 |
29 |
4 |
p. 813-820 8 p. |
article |
13 |
Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection
|
Zheng, Qun |
|
2011 |
29 |
4 |
p. 763-771 9 p. |
article |
14 |
Evaluation of safety and protection efficacy on cpxR and lon deleted mutant of Salmonella Gallinarum as a live vaccine candidate for fowl typhoid
|
Matsuda, Kiku |
|
2011 |
29 |
4 |
p. 668-674 7 p. |
article |
15 |
Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis
|
Hoseinian Khosroshahi, K. |
|
2011 |
29 |
4 |
p. 778-783 6 p. |
article |
16 |
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis
|
Dziadek, Bozena |
|
2011 |
29 |
4 |
p. 821-830 10 p. |
article |
17 |
Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge
|
Moustafa, Dina |
|
2011 |
29 |
4 |
p. 784-794 11 p. |
article |
18 |
Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in Mice and Ferrets
|
Yang, PengHui |
|
2011 |
29 |
4 |
p. 698-705 8 p. |
article |
19 |
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation
|
Dolter, Karen E. |
|
2011 |
29 |
4 |
p. 795-803 9 p. |
article |
20 |
Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity
|
Hallengärd, David |
|
2011 |
29 |
4 |
p. 839-848 10 p. |
article |
21 |
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions
|
Baldwin, Susan L. |
|
2011 |
29 |
4 |
p. 644-649 6 p. |
article |
22 |
Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation
|
Li, Yaoming |
|
2011 |
29 |
4 |
p. 855-862 8 p. |
article |
23 |
In vitro analysis of the factors contributing to the antiviral state induced by a plasmid encoding the viral haemorrhagic septicaemia virus glycoprotein G in transfected trout cells
|
Ortega-Villaizan, M. |
|
2011 |
29 |
4 |
p. 737-743 7 p. |
article |
24 |
LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb
|
Nawar, Hesham F. |
|
2011 |
29 |
4 |
p. 721-727 7 p. |
article |
25 |
Pandemic 2009–2010 influenza vaccine: Six lessons learned and the way forward (Allegro not Adagio)
|
Poland, Gregory A. |
|
2011 |
29 |
4 |
p. 613-614 2 p. |
article |
26 |
PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration
|
Stano, Armando |
|
2011 |
29 |
4 |
p. 804-812 9 p. |
article |
27 |
Recombinant proteins containing the hypervariable region of the haemagglutinin protect chickens against challenge with Avibacterium paragallinarum
|
Wu, Jin-Ru |
|
2011 |
29 |
4 |
p. 660-667 8 p. |
article |
28 |
Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients
|
Meerveld-Eggink, A. |
|
2011 |
29 |
4 |
p. 675-680 6 p. |
article |
29 |
Response to letter to editor responding to article by Shrestha SS, Wallace GS, Meltzer MI. Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences [Vaccine 2010; 28:6318–6332]
|
Shrestha, Sundar S. |
|
2011 |
29 |
4 |
p. 616- 1 p. |
article |
30 |
Response to “Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences”
|
Proano, Ruben A. |
|
2011 |
29 |
4 |
p. 615- 1 p. |
article |
31 |
Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine
|
Chao, Day-Yu |
|
2011 |
29 |
4 |
p. 617-623 7 p. |
article |
32 |
The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents
|
Eberly, Matthew D. |
|
2011 |
29 |
4 |
p. 650-659 10 p. |
article |
33 |
Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine
|
Chen, Jie |
|
2011 |
29 |
4 |
p. 706-711 6 p. |
article |
34 |
Towards an immunosense vaccine to prevent toxoplasmosis: Protective Toxoplasma gondii epitopes restricted by HLA-A*0201
|
Cong, Hua |
|
2011 |
29 |
4 |
p. 754-762 9 p. |
article |
35 |
Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA
|
Neal, Lori M. |
|
2011 |
29 |
4 |
p. 681-689 9 p. |
article |
36 |
Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi
|
Micoli, F. |
|
2011 |
29 |
4 |
p. 712-720 9 p. |
article |